Fitness PR Division

Many people not only struggle to lose weight but also have trouble when trying to quit smoking. Fortunately, a single drug called Acomplia could solve both problems.

There’s a long list of foods that bodybuilders and other athletes try to avoid. Among these are fast foods, fattening snacks, and sugary drinks as long-term or excessive consumption of these kinds of foods can leave a person overweight and forced to deal with multiple health problems. But eating stuff like this is often a nasty habit that some athletes just can’t seem to shake no matter how hard they try.

An even nastier habit that athletes can fall into is smoking which might be even more detrimental to one’s physical goals. Smoking leads to increased blood pressure and heart rate as well as various lung diseases and none of this adds up to bettering one’s body. Obviously, the combination of fatty foods and smoking equals a decrease in one’s athletic performance.

So athletes and people alike often need to turn to various drugs to curb the disastrous effects that such habits can create. Unfortunately, this usually means that they have to take both a dieting drug and a smoking cessation drug separately in order to fulfill both needs. But imagine if there was a drug that could satisfy the two demands. No longer would people be required to take multiple medications in order to keep their weight down and their nicotine cravings in check.

In the last week GlaxoSmithKline has had a PR crisis on their hands as the story broke that counterfeit alli, the over the counter weight loss drug, was being sold on eBay. While many times counterfeit anything is made to be similar to the real thing, there is one major difference with the counterfeit diet pill: it contains sibutramine. Sibutramine is something that is typically the ingredient in Dr. prescribed weight loss medications, therefore it can be dangerous to the health of those who unknowingly take it.

GSK has already begun to take steps to warn the public by the alert posted on their main website. They are working closely with eBay to deal with this issue and news outlets are beginning to spread the story.

Here are some PR suggestions to what other things they need to do during this time:

Most women will sacrifice comfort for fashion, especially when it comes to wearing a gorgeous pair of high heels that 'make' an outfit. Unfortunately, over time, the fat pad at the ball of the foot thins and shifts so bones are not as well padded. Combine these changes with a heel height over two inches and it's a recipe for foot pain. "Now there is an alternative to forsaking your favorite pair of sky high Louboutins," states Dr. Archer. "The same dermal filler that is used in the face to fill deep lines and make us look younger can also make our feet feel younger.  Sculptra is placed where fat has been lost under the bones in the balls of the feet thereby restoring padding and allowing women to wear their high heels again. The great advantage of using Sculptra over other dermal fillers is that it causes the skin to thicken by building collagen. Its effects are longer lasting, usually up to one year."  

Sculptra, or poly-L-lactic acid (PLLA), is an FDA approved injectable dermal filler used by many cosmetic surgeons, such as Dr. Amiya Prasad on Manhattan's upper-east-side. "As we get older we lose volume in the face resulting in hollowing," states Dr. Prasad. "We routinely use Sculptra to create a uniform restoration of lost facial volume in the temples, the cheeks and also to accentuate the cheek bones."

Most women will sacrifice comfort for fashion, especially when it comes to wearing a gorgeous pair of high heels that 'make' an outfit. Unfortunately, over time, the fat pad at the ball of the foot thins and shifts so bones are not as well padded. Combine these changes with a heel height over two inches and it's a recipe for foot pain. "Now there is an alternative to forsaking your favorite pair of sky high Louboutins," states Dr. Archer. "The same dermal filler that is used in the face to fill deep lines and make us look younger can also make our feet feel younger.  Sculptra is placed where fat has been lost under the bones in the balls of the feet thereby restoring padding and allowing women to wear their high heels again. The great advantage of using Sculptra over other dermal fillers is that it causes the skin to thicken by building collagen. Its effects are longer lasting, usually up to one year."  

Sculptra, or poly-L-lactic acid (PLLA), is an FDA approved injectable dermal filler used by many cosmetic surgeons, such as Dr. Amiya Prasad on Manhattan's upper-east-side. "As we get older we lose volume in the face resulting in hollowing," states Dr. Prasad. "We routinely use Sculptra to create a uniform restoration of lost facial volume in the temples, the cheeks and also to accentuate the cheek bones."

Most women will sacrifice comfort for fashion, especially when it comes to wearing a gorgeous pair of high heels that 'make' an outfit. Unfortunately, over time, the fat pad at the ball of the foot thins and shifts so bones are not as well padded. Combine these changes with a heel height over two inches and it's a recipe for foot pain. "Now there is an alternative to forsaking your favorite pair of sky high Louboutins," states Dr. Archer. "The same dermal filler that is used in the face to fill deep lines and make us look younger can also make our feet feel younger.  Sculptra is placed where fat has been lost under the bones in the balls of the feet thereby restoring padding and allowing women to wear their high heels again. The great advantage of using Sculptra over other dermal fillers is that it causes the skin to thicken by building collagen. Its effects are longer lasting, usually up to one year."  

Sculptra, or poly-L-lactic acid (PLLA), is an FDA approved injectable dermal filler used by many cosmetic surgeons, such as Dr. Amiya Prasad on Manhattan's upper-east-side. "As we get older we lose volume in the face resulting in hollowing," states Dr. Prasad. "We routinely use Sculptra to create a uniform restoration of lost facial volume in the temples, the cheeks and also to accentuate the cheek bones."

Wellness PR: Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for the prophylactic (preventive) treatment of headaches in adults with Chronic Migraine, a distinct and severe neurological disorder characterized by patients who have a history of migraine and suffer from headaches on 15 or more days per month with headaches lasting four hours a day or longer. BOTOX is the first clinically studied prophylactic treatment to be approved by the FDA specifically for this debilitated patient population. When injected at labeled doses and in the recommended locations in the head and neck, BOTOX is expected to produce results lasting up to three months depending on the individual patient.

Wellness PR: Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for the prophylactic (preventive) treatment of headaches in adults with Chronic Migraine, a distinct and severe neurological disorder characterized by patients who have a history of migraine and suffer from headaches on 15 or more days per month with headaches lasting four hours a day or longer. BOTOX is the first clinically studied prophylactic treatment to be approved by the FDA specifically for this debilitated patient population. When injected at labeled doses and in the recommended locations in the head and neck, BOTOX is expected to produce results lasting up to three months depending on the individual patient.

Wellness PR: Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for the prophylactic (preventive) treatment of headaches in adults with Chronic Migraine, a distinct and severe neurological disorder characterized by patients who have a history of migraine and suffer from headaches on 15 or more days per month with headaches lasting four hours a day or longer. BOTOX is the first clinically studied prophylactic treatment to be approved by the FDA specifically for this debilitated patient population. When injected at labeled doses and in the recommended locations in the head and neck, BOTOX is expected to produce results lasting up to three months depending on the individual patient.

Wellness PR: Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for the prophylactic (preventive) treatment of headaches in adults with Chronic Migraine, a distinct and severe neurological disorder characterized by patients who have a history of migraine and suffer from headaches on 15 or more days per month with headaches lasting four hours a day or longer. BOTOX is the first clinically studied prophylactic treatment to be approved by the FDA specifically for this debilitated patient population. When injected at labeled doses and in the recommended locations in the head and neck, BOTOX is expected to produce results lasting up to three months depending on the individual patient.

Wellness PR: Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for the prophylactic (preventive) treatment of headaches in adults with Chronic Migraine, a distinct and severe neurological disorder characterized by patients who have a history of migraine and suffer from headaches on 15 or more days per month with headaches lasting four hours a day or longer. BOTOX is the first clinically studied prophylactic treatment to be approved by the FDA specifically for this debilitated patient population. When injected at labeled doses and in the recommended locations in the head and neck, BOTOX is expected to produce results lasting up to three months depending on the individual patient.

Wellness PR: Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for the prophylactic (preventive) treatment of headaches in adults with Chronic Migraine, a distinct and severe neurological disorder characterized by patients who have a history of migraine and suffer from headaches on 15 or more days per month with headaches lasting four hours a day or longer. BOTOX is the first clinically studied prophylactic treatment to be approved by the FDA specifically for this debilitated patient population. When injected at labeled doses and in the recommended locations in the head and neck, BOTOX is expected to produce results lasting up to three months depending on the individual patient.